Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Randomized Trial of Anticoagulation Strategies for Noncritically Ill Patients Hospitalized With COVID-19
Gregg W. Stone, Michael E. Farkouh, Anuradha Lala, et al.
Journal of the American College of Cardiology (2023) Vol. 81, Iss. 18, pp. 1747-1762
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19
Sam Schulman, Donald M. Arnold, Charlotte Bradbury, et al.
Journal of Thrombosis and Haemostasis (2024) Vol. 22, Iss. 6, pp. 1779-1797
Open Access | Times Cited: 18
2024 Guideline for the Primary Prevention of Stroke: A Guideline From the American Heart Association/American Stroke Association
Cheryl Bushnell, Walter N. Kernan, Anjail Sharrief, et al.
Stroke (2024) Vol. 55, Iss. 12
Closed Access | Times Cited: 16
Appropriate thromboprophylaxis strategy for COVID-19 patients on dosage, antiplatelet therapy, outpatient and post-discharge prophylaxis: a meta-analysis of randomized controlled trials
Jiahao Meng, Hang Tang, Yifan Xiao, et al.
International Journal of Surgery (2024)
Open Access | Times Cited: 8
National Institutes of Health COVID-19 Treatment Guidelines Panel: Perspectives and Lessons Learned
Roy M. Gulick, Alice K. Pau, Eric S. Daar, et al.
Annals of Internal Medicine (2024) Vol. 177, Iss. 11, pp. 1547-1557
Closed Access | Times Cited: 8
Clinical implications of COVID-19 in chronic kidney disease and end-stage kidney disease
Paul Cockwell, Matthew D. Griffin
Elsevier eBooks (2025), pp. 543-568
Closed Access
Hypercoagulability in COVID-19
Ryan Geffin, Likhita Nandigam, Mayra L. Mesa, et al.
Elsevier eBooks (2025), pp. 387-407
Closed Access
Therapeutic Versus Non‐Therapeutic Dose Anticoagulation in COVID‐19 Infection: A Systematic Review and Meta‐analysis of Randomised Controlled Trials
Sushil Selvarajan, Jisha Sara John, Prathap Tharyan, et al.
eJHaem (2025) Vol. 6, Iss. 1
Open Access
Predictors of venous thromboembolic events in hospitalized patients with COVID-19
Giovanni Scimeca, Darsiya Krishnathasan, Sina Rashedi, et al.
Journal of Thrombosis and Thrombolysis (2025)
Closed Access
Myocardial Oedema as a Consequence of Viral Infection and Persistence—A Narrative Review with Focus on COVID-19 and Post COVID Sequelae
N Panagiotides, Michael Poledniczek, Martin Andreas, et al.
Viruses (2024) Vol. 16, Iss. 1, pp. 121-121
Open Access | Times Cited: 4
Initial therapeutic anticoagulation with rivaroxaban compared to prophylactic therapy with heparins in moderate to severe COVID-19: results of the COVID-PREVENT randomized controlled trial
Ursula Rauch‐Kröhnert, Marianna Puccini, Marius Placzek, et al.
Clinical Research in Cardiology (2023) Vol. 112, Iss. 11, pp. 1620-1638
Open Access | Times Cited: 10
Choice and Duration of Anticoagulation for Venous Thromboembolism
Aroosa Malik, Nghi B. Ha, Geoffrey D. Barnes
Journal of Clinical Medicine (2024) Vol. 13, Iss. 1, pp. 301-301
Open Access | Times Cited: 3
Antiplatelet therapy prior to COVID-19 infection impacts on patients mortality: a propensity score-matched cohort study
Mateusz Sokolski, Konrad Reszka, Barbara Adamik, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Anticoagulation in COVID-19 patients – An updated systematic review and meta-analysis
Stefanie Reis, Amon Faske, Ina Monsef, et al.
Thrombosis Research (2024) Vol. 238, pp. 141-150
Open Access | Times Cited: 3
Comparative analysis of COVID-19-associated venous thromboembolism outcomes: evolution from 2020 to 2021–2022
Francisco Galeano‐Valle, Pablo Demelo-Rodríguez, Rubén Alonso-Beato, et al.
Journal of Thrombosis and Thrombolysis (2024) Vol. 57, Iss. 7, pp. 1239-1248
Closed Access | Times Cited: 2
The COVID-19 thrombus: distinguishing pathological, mechanistic, and phenotypic features and management
Richard C. Becker, Udaya S. Tantry, Muhammad H Khan, et al.
Journal of Thrombosis and Thrombolysis (2024)
Open Access | Times Cited: 2
Cerebrovascular Disease in COVID-19
James E. Siegler, Savanna Dasgupta, Mohamad Abdalkader, et al.
Viruses (2023) Vol. 15, Iss. 7, pp. 1598-1598
Open Access | Times Cited: 5
Heparin Dose Intensity and Organ Support-Free Days in Patients Hospitalized for COVID-19
Lucas C. Godoy, Matthew D. Neal, Ewan C. Goligher, et al.
JACC Advances (2024) Vol. 3, Iss. 3, pp. 100780-100780
Open Access | Times Cited: 1
Inflammatory risk contributes to post-COVID endothelial dysfunction through anti-ACKR1 autoantibody
Ee Soo Lee, Nhi Nguyen, Barnaby Edward Young, et al.
Life Science Alliance (2024) Vol. 7, Iss. 7, pp. e202402598-e202402598
Open Access | Times Cited: 1
COVID-19 Infection and St-Elevation Myocardial Infarction: Lessons in Disease Management During a Pandemic
A.J. Carmichael, Joseph T Hale, Shahnawaz Notta, et al.
Cureus (2024)
Open Access | Times Cited: 1
Effect of amubarvimab-romlusevimab for treatment of severe COVID-19 in intensive care units: a retrospective cohort study
Peng Qu, Anni Lou, Dan Rong, et al.
Heliyon (2024) Vol. 10, Iss. 18, pp. e37663-e37663
Open Access | Times Cited: 1
Anticoagulation Among Patients Hospitalized for COVID-19
Claire L. Vale, Peter J. Godolphin, David J. Fisher, et al.
Annals of Internal Medicine (2024)
Closed Access | Times Cited: 1
Cerebrovascular Disease in COVID-19
James E. Siegler, Savanna Dasgupta, Mohamad Abdalkader, et al.
(2023)
Open Access | Times Cited: 3
An Evolving Understanding of the Basis and Management of Vascular Complications of COVID-19: Where Do We Go From Here?
Yishay Szekely, Rami Gilead, Ana Beatriz B.A.C. Réa, et al.
Canadian Journal of Cardiology (2023) Vol. 39, Iss. 6, pp. 865-874
Open Access | Times Cited: 2
Low-molecular-weight heparin for the prevention of clinical worsening in severe non-critically ill COVID-19 patients: a joint analysis of two randomized controlled trials
Maddalena Alessandra Wu, Cinzia Del Giovane, Riccardo Colombo, et al.
Internal and Emergency Medicine (2023) Vol. 19, Iss. 1, pp. 71-79
Closed Access | Times Cited: 2
COVID-19: An Update on Epidemiology, Prevention and Treatment, September-2023
Serap Şimşek Yavuz
Infectious Diseases and Clinical Microbiology (2023) Vol. 5, Iss. 3, pp. 165-187
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top